• https://desatlogobendung.gresikkab.go.id/vendor/x-ais.app/
  • https://kec-moyoutara.sumbawakab.go.id/files/app/
  • https://mpp.pangandarankab.go.id/public/assets/xais/
  • https://disnak.jatimprov.go.id/js/app.js/
  • This site is part of the Siconnects Division of Sciinov Group

    This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

    ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

    Registration

    Hypertension drug could be repurposed to delay ageing, study finds

    23 JAN , 2023

    Researchers have found that the drug rilmenidine can extend lifespan and slow ageing.
    Published in Aging Cell, the findings show that animals treated with rilmenidine, currently used to treat hypertension, at young and older ages increases lifespan and improves health markers, mimicking the effects of caloric restriction.


    They also demonstrate that the healthspan and lifespan benefits of rilmenidine treatment in the roundworm C. elegans are mediated by the I1-imidazoline receptor nish-1, identifying this receptor as a potential longevity target.


    Unlike other drugs previously studied for this purpose by the researchers, the widely-prescribed, oral antihypertensive rilmenidine has potential for future translatability to humans as side-effects are rare and non-severe.


    To date, a caloric restriction diet has been considered the most robust anti-aging intervention, promoting longevity across species. However, studies of caloric restriction in humans have had mixed results and side effects, meaning finding medications like rilmenidine that can mimic the benefits of caloric restriction is the most reasonable anti-aging strategy.

    Source: https://news.liverpool.ac.uk/2023/01/23/hypertension-drug-could-be-repurposed-to-delay-ageing-study-finds/

     


    Subscribe to our News & Updates